Seasoned operator and investor focused on growth-stage technology and consumer sectors, with cross-functional experience in product strategy, corporate development and board governance. Nicole Reese brings strategic sourcing of growth capital, go-to-market scaling and M&A execution to portfolio companies, and is known for hands-on operational support to founders and CFOs. Frequently engages with VC and growth-equity firms to structure minority and control investments and drive commercial traction.
Seasoned operator and investor focused on growth-stage technology and consumer sectors, with cross-functional experience in product strategy, corporate development and board governance. Nicole Reese brings strategic sourcing of growth capital, go-to-market scaling and M&A execution to portfolio companies, and is known for hands-on operational support to founders and CFOs. Frequently engages with VC and growth-equity firms to structure minority and control investments and drive commercial traction.
Operates as a growth-stage investor prioritizing technology and consumer businesses with product-led expansion and repeatable go-to-market models. Prefers minority and structured control positions sized to catalyze scaling, using capital plus hands-on operational support in product strategy, commercial execution and M&A to accelerate value creation. Underwrites opportunities with emphasis on clear unit economics, scalable revenue channels and founder alignment, favors multi-year time horizons, active governance, and pragmatic risk mitigation via staged capital and performance-based milestones.
Operates as a growth-stage investor prioritizing technology and consumer businesses with product-led expansion and repeatable go-to-market models. Prefers minority and structured control positions sized to catalyze scaling, using capital plus hands-on operational support in product strategy, commercial execution and M&A to accelerate value creation. Underwrites opportunities with emphasis on clear unit economics, scalable revenue channels and founder alignment, favors multi-year time horizons, active governance, and pragmatic risk mitigation via staged capital and performance-based milestones.
| Trades 7755 | Longs Won 4301/7755 55% | Profit Factor 5.59 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $54,296.07 |
| Average Win $8,663.45 | Best Trade (Oct 15) $3.59M | Sharpe Ratio -8.65 |
| Average Loss -$1,929.17 | Worst Trade (Oct 15) -$361,177.03 | Z-Score 7.98 (100%) |
| Commissions $0 | Avg. Trade Length 10m 4w | Expectancy $3,945.59 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 83,333 | 75,000 | 66,667 | 58,333 | 50,000 | 41,667 | 33,333 | 25,000 | 16,667 | 8,333 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
A Agilent Technologies Inc. | 45 | $6,045.25 | $7,899.75 | - | $1,854.5 | 30.68% | +0.891% |
AA Alcoa Corporation | 54 | $3,440.48 | $2,182.68 | - | -$1,257.8 | -36.56% | +0.848% |
AAL American Airlines Group Inc. | 1,256 | $14,718.99 | $15,423.68 | - | $704.69 | 4.79% | +4.156% |
AAOI Applied Optoelectronics, Inc. | 48 | $4,060 | $4,019.04 | - | -$40.96 | -1.01% | -2.888% |
AAON Aaon Inc. | 36 | $4,225.4 | $2,782.8 | - | -$1,442.6 | -34.14% | -4.011% |
AAPL Apple Inc. | 9,661 | $2.45M | $3.3M | - | $852,986.58 | 34.8% | -0.28% |
AAT American Assets Trust, Inc. | 26 | $683 | $557.7 | - | -$125.3 | -18.35% | +1.179% |
AAXJ iShares MSCI All Country Asia ex Japan ETF | 6 | $433 | $662.16 | - | $229.16 | 52.92% | -0.791% |
ABBV AbbVie Inc. | 395 | $75,952.72 | $111,935.1 | - | $35,982.38 | 47.37% | +0.579% |
ABM ABM Industries Inc. | 524 | $23,182 | $26,598.24 | - | $3,416.24 | 14.74% | +0.237% |
ABNB Airbnb, Inc. | 4 | $477.85 | $697.12 | - | $219.27 | 45.89% | +4.322% |
ABT Abbott Laboratories | 527 | $58,360.66 | $55,171.63 | - | -$3,189.03 | -5.46% | +2.296% |
ABVX Abivax SA ADR | 432 | $49,791.49 | $39,908.16 | - | -$9,883.33 | -19.85% | +5.001% |
ABX Abacus Global Management, Inc. | 66 | $494 | $522.72 | - | $28.72 | 5.81% | +2.458% |
ACAD Acadia Pharmaceuticals Inc. | 190 | $4,297.47 | $3,744.9 | - | -$552.57 | -12.86% | +2.39% |
ACGL Arch Capital Group Ltd | 52 | $4,912.62 | $5,164.12 | - | $251.5 | 5.12% | +1.752% |
ACHC Acadia Healthcare Company, Inc. | 57 | $2,259.94 | $1,767.57 | - | -$492.37 | -21.79% | -2.084% |
ACI Albertsons Companies, Inc. | 2,243 | $44,496.97 | $29,226.29 | - | -$15,270.68 | -34.32% | -0.382% |
ACIW ACI Worldwide, Inc. | 25 | $1,297.84 | $1,313.75 | - | $15.91 | 1.23% | +2.898% |
ACLS Axcelis Technologies, Inc. | 46 | $5,919.76 | $5,295.06 | - | -$624.7 | -10.55% | -2.951% |